Effect of vitamin D supplementation alone on muscle function in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial - PubMed (original) (raw)
Randomized Controlled Trial
. 2015 Oct;26(10):2413-21.
doi: 10.1007/s00198-015-3151-9. Epub 2015 May 9.
Affiliations
- PMID: 25956283
- DOI: 10.1007/s00198-015-3151-9
Randomized Controlled Trial
Effect of vitamin D supplementation alone on muscle function in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial
L M Cangussu et al. Osteoporos Int. 2015 Oct.
Abstract
The present study investigates the effects of vitamin D on muscle function in postmenopausal women. It has been shown that vitamin D supplementation in postmenopausal women with hypovitaminosis D provides significant protective factor against sarcopenia, with significant increases in muscle strength and control of progressive loss of lean mass.
Introduction: We aimed to evaluate the effect of supplementation of vitamin D (VITD) alone on muscle function in younger postmenopausal women.
Methods: In this double-blind, placebo-controlled clinical trial, 160 Brazilian postmenopausal women were randomized into two groups: VITD group consisting of patients receiving vitamin D3 1000 IU/day orally (n = 80) or placebo group (n = 80). Women with amenorrhea for more than 12 months and age 50-65 years, with a history of falls (previous 12 months), were included. The intervention time was 9 months, with assessments at two points, start and end. Lean mass was estimated by total-body dual-energy X-ray absorptiometry (DXA) and muscle strength by handgrip strength and chair rising test. The plasma concentrations of 25-hydroxyvitamin D [25(OH)D] were measured by high-performance liquid chromatography (HPLC). Statistical analysis was by intention to treat (ITT), using ANOVA, Student's t test, and Tukey's test.
Results: After 9 months, average values of 25(OH)D increased from 15.0 ± 7.5 to 27.5 ± 10.4 ng/ml (+45.4%) in the VITD group and decreased from 16.9 ± 6.7 to 13.8 ± 6.0 ng/ml (-18.5%) in the placebo group (p < 0.001). In the VITD group, there was significant increase in muscle strength (+25.3%) of the lower limbs by chair rising test (p = 0.036). In women in the placebo group, there was considerable loss (-6.8%) in the lean mass (p = 0.030).
Conclusion: The supplementation of vitamin D alone in postmenopausal women provided significant protective factor against the occurrence of sarcopenia, with significant increases in muscle strength and control of progressive loss of lean mass.
Keywords: Lean mass; Menopause; Muscle function; Vitamin D.
Similar articles
- Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
Nahas-Neto J, Cangussu LM, Orsatti CL, Bueloni-Dias FN, Poloni PF, Schmitt EB, Nahas EAP. Nahas-Neto J, et al. Osteoporos Int. 2018 May;29(5):1125-1133. doi: 10.1007/s00198-018-4395-y. Epub 2018 Feb 15. Osteoporos Int. 2018. PMID: 29450585 Clinical Trial. - Effect of isolated vitamin D supplementation on the rate of falls and postural balance in postmenopausal women fallers: a randomized, double-blind, placebo-controlled trial.
Cangussu LM, Nahas-Neto J, Orsatti CL, Poloni PF, Schmitt EB, Almeida-Filho B, Nahas EA. Cangussu LM, et al. Menopause. 2016 Mar;23(3):267-74. doi: 10.1097/GME.0000000000000525. Menopause. 2016. PMID: 26554884 Clinical Trial. - The effect of vitamin D2 supplementation on muscle strength in early postmenopausal women: a randomized, double-blind, placebo-controlled trial.
Suebthawinkul C, Panyakhamlerd K, Yotnuengnit P, Suwan A, Chaiyasit N, Taechakraichana N. Suebthawinkul C, et al. Climacteric. 2018 Oct;21(5):491-497. doi: 10.1080/13697137.2018.1480600. Epub 2018 Aug 10. Climacteric. 2018. PMID: 30095022 Clinical Trial. - The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Rizzoli R, Stevenson JC, Bauer JM, van Loon LJ, Walrand S, Kanis JA, Cooper C, Brandi ML, Diez-Perez A, Reginster JY; ESCEO Task Force. Rizzoli R, et al. Maturitas. 2014 Sep;79(1):122-32. doi: 10.1016/j.maturitas.2014.07.005. Epub 2014 Jul 17. Maturitas. 2014. PMID: 25082206 - Effects of Vitamin D Supplementation on Muscle Strength in Athletes: A Systematic Review.
Chiang CM, Ismaeel A, Griffis RB, Weems S. Chiang CM, et al. J Strength Cond Res. 2017 Feb;31(2):566-574. doi: 10.1519/JSC.0000000000001518. J Strength Cond Res. 2017. PMID: 27379960 Review.
Cited by
- Vitamin D in pituitary driven osteopathies.
Chiloiro S, Costanza F, Riccardi E, Giampietro A, De Marinis L, Bianchi A, Pontecorvi A, Giustina A. Chiloiro S, et al. Pituitary. 2024 Aug 24. doi: 10.1007/s11102-024-01439-3. Online ahead of print. Pituitary. 2024. PMID: 39180644 Review. - The Role of Sarcopenia in Heart Failure with Depression.
Wang R, Duan J, Liu W, Huang K, Chen Z, Yang C, Yang L. Wang R, et al. Rev Cardiovasc Med. 2022 Sep 5;23(9):296. doi: 10.31083/j.rcm2309296. eCollection 2022 Sep. Rev Cardiovasc Med. 2022. PMID: 39077715 Free PMC article. Review. - Genetic Variants, Serum 25-Hydroxyvitamin D Levels, and Sarcopenia: A Mendelian Randomization Analysis.
Sha T, Wang Y, Zhang Y, Lane NE, Li C, Wei J, Zeng C, Lei G. Sha T, et al. JAMA Netw Open. 2023 Aug 1;6(8):e2331558. doi: 10.1001/jamanetworkopen.2023.31558. JAMA Netw Open. 2023. PMID: 37647062 Free PMC article. - Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly.
Chiloiro S, Frara S, Gagliardi I, Bianchi A, Giampietro A, Medici M, Allora A, di Filippo L, Ambrosio MR, Pontecorvi A, Zatelli MC, De Marinis L, Giustina A. Chiloiro S, et al. J Clin Endocrinol Metab. 2023 Dec 21;109(1):e58-e68. doi: 10.1210/clinem/dgad493. J Clin Endocrinol Metab. 2023. PMID: 37606222 Free PMC article. - Alternative skeletal muscle index for sarcopenia diagnosis in elderly patients with type 2 diabetes mellitus: A pilot study.
Lu L, Liu B, Yin F. Lu L, et al. Front Endocrinol (Lausanne). 2023 Feb 9;14:1083722. doi: 10.3389/fendo.2023.1083722. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843587 Free PMC article.
References
- Maturitas. 2012 Jan;71(1):83-8 - PubMed
- N Engl J Med. 2007 Jul 19;357(3):266-81 - PubMed
- Endocr Rev. 2013 Feb;34(1):33-83 - PubMed
- J Br Menopause Soc. 2005 Jun;11(2):45-50 - PubMed
- J Clin Endocrinol Metab. 2014 Nov;99(11):4336-45 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical